|
| 37552498 | Hybrid Schwannoma-Perineurioma of the Orbit. | Ophthalmic Plast Reconstr Surg | 2024 |
| 37591790 | pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. | Neuro Oncol | 2024 |
| 37552498 | Hybrid Schwannoma-Perineurioma of the Orbit. | Ophthalmic Plast Reconstr Surg | 2024 |
| 37591790 | pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. | Neuro Oncol | 2024 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 36273330 | Epigenetic upregulation of Schlafen11 renders ⿨WNT- and SHH-activated medulloblastomas sensitive to cisplatin. | Neuro Oncol | 2023 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 37837311 | Orbital SOX10-mutant schwannoma with plexiform growth: Expanding the histopathological spectrum of a new molecular group. | J Neuropathol Exp Neurol | 2023 |
| 37738646 | Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation. | Neuro Oncol | 2023 |
| 36840626 | Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. | Neuro Oncol | 2023 |
| 37498309 | A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma. | Clin Cancer Res | 2023 |
| 37837311 | Orbital SOX10-mutant schwannoma with plexiform growth: Expanding the histopathological spectrum of a new molecular group. | J Neuropathol Exp Neurol | 2023 |
| 37738646 | Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation. | Neuro Oncol | 2023 |
| 37498309 | A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma. | Clin Cancer Res | 2023 |
| 36840626 | Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. | Neuro Oncol | 2023 |
| 36273330 | Epigenetic upregulation of Schlafen11 renders ⿨WNT- and SHH-activated medulloblastomas sensitive to cisplatin. | Neuro Oncol | 2023 |
| 34297428 | RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas. | Brain Pathol | 2022 |
| 35459782 | Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. | Oncogene | 2022 |
| 36359362 | Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib. | Biomedicines | 2022 |
| 35754178 | The WHO classification of tumors of the central nervous system-finally here, and welcome! | Brain Pathol | 2022 |
| 35561840 | Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens. | Hum Pathol | 2022 |
| 35740680 | Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid Tumors. | Cancers (Basel) | 2022 |
| 35419593 | Correction: Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. | Clin Cancer Res | 2022 |
| 35986378 | Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling. | Acta Neuropathol Commun | 2022 |
| 35534540 | Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. | Oncogene | 2022 |
| 34297428 | RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas. | Brain Pathol | 2022 |
| 35175291 | Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. | Arch Pathol Lab Med | 2022 |
| 35152461 | Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC. | Neuropathol Appl Neurobiol | 2022 |
| 35148513 | Clinical features and surgical outcomes of intracranial and spinal cord subependymomas. | J Neurosurg | 2022 |
| 34821426 | Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. | Brain Pathol | 2022 |
| 34698334 | Clinicopathologic and Proteomic Analysis of Amyloidomas Involving the Ocular Surface and Adnexa. | Am J Clin Pathol | 2022 |
| 35085662 | Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. | Ophthalmology | 2022 |
| 35740680 | Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid Tumors. | Cancers (Basel) | 2022 |
| 35534540 | Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. | Oncogene | 2022 |
| 35459782 | Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. | Oncogene | 2022 |
| 35754178 | The WHO classification of tumors of the central nervous system-finally here, and welcome! | Brain Pathol | 2022 |
| 35419593 | Correction: Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. | Clin Cancer Res | 2022 |
| 35561840 | Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens. | Hum Pathol | 2022 |
| 36359362 | Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib. | Biomedicines | 2022 |
| 35986378 | Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling. | Acta Neuropathol Commun | 2022 |
| 35152461 | Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC. | Neuropathol Appl Neurobiol | 2022 |
| 35148513 | Clinical features and surgical outcomes of intracranial and spinal cord subependymomas. | J Neurosurg | 2022 |
| 35175291 | Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. | Arch Pathol Lab Med | 2022 |
| 35085662 | Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. | Ophthalmology | 2022 |
| 34821426 | Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. | Brain Pathol | 2022 |
| 34698334 | Clinicopathologic and Proteomic Analysis of Amyloidomas Involving the Ocular Surface and Adnexa. | Am J Clin Pathol | 2022 |
| 32699955 | Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review. | Skeletal Radiol | 2021 |
| 37284624 | Molecular clarification of brainstem astroblastoma with EWSR1-BEND2 fusion in a 38-year-old man. | Free Neuropathol | 2021 |
| 33591953 | Chromosome 8 gain is associated with high-grade transformation in MPNST. | JCI Insight | 2021 |
| 33588442 | Diagnostic Pathology of Tumors of Peripheral Nerve. | Neurosurgery | 2021 |